XGN (NASDAQ) - 30-Min Chart Long Trade Setup !๐
๐ Stock: XGN (NASDAQ)
โณ Timeframe: 30-Min Chart
๐ Setup Type: Bullish Breakout
๐ Trade Plan:
โ
Entry Zone: Above $5.45 - $5.50 (Breakout Confirmation)
๐ Take Profit 1 (TP1): $6.00 (First Resistance)
๐ Take Profit 2 (TP2): $6.54 (Extended Bullish Target)
๐ป Stop-Loss (SL): Below $4.98 (Key Support)
๐ Risk-Reward Ratio: Favorable for a bullish continuation ๐
๐น Technical Analysis & Setup:
โ
Pattern: Bullish Pennant Breakout ๐
โ
Breakout Confirmation Needed: Price holding above $5.45 with volume support
โ
Resistance Zones:
$6.00: First Major Resistance
$6.54: Extended Target for strong momentum
โ
Momentum Shift Expected: A breakout could trigger a strong uptrend ๐
๐ฅ Trade Strategy & Refinements:
๐ Volume Confirmation: Look for increasing buying volume above $5.45 ๐
๐ Trailing Stop Strategy: Once price reaches TP1 ($6.00), adjust SL higher to secure profits ๐
๐ฐ Partial Profit Booking: Take partial profits at $6.00 and let the rest ride toward $6.54+ ๐ต
โ ๏ธ Fake Breakout Risk: If price drops back below $5.45, reconsider entry โ
๐ Final Thoughts:
โ
Bullish Breakout Potential โ High probability of continuation higher ๐
โ
Momentum Shift Possible โ A move above $6.00 could accelerate the upside ๐
โ
Strong Risk-Reward Setup โ SL at $4.98, TP at $6.00 - $6.54 for optimal gains
๐ Trade Smart & Stick to the Plan! ๐๐ฅ
๐ #LongTrade #StockTrading #XGN #TechnicalAnalysis #DayTrading #MomentumTrading #BreakoutSetup #RiskReward #TradingPlan #ProfittoPath ๐๐
XGN trade ideas
Exagen (bottom?)Ce
I appreciate your attention to my analysis.
I find the charts intriguing, particularly the concepts of "total destruction" and "buying in blood." Despite the short-term risks, the potential for significant gains, such as 10x, 50x, or even 100x returns in the long term, is undeniable.
Upon closer examination of the chart, it appears that shorting activities have lost momentum recently, while earnings have shown consistent growth, with approximately 92% in the green. Although attempts to initiate a short squeeze in recent months resulted in a bull trap, the current situation presents a crucial juncture that appears heavily bearish, yet potentially ripe for the taking.
Regarding the skepticism surrounding the possibility of the stock reaching $1, the remarkably low market cap suggests an underestimation of its potential. I firmly believe that this stock's trajectory is far from its conclusion; rather, it signals the dawn of a promising future.
(Exagen Inc. is a diagnostic company specializing in autoimmune diseases, notably lupus and rheumatoid arthritis.)
EXAGEN (XGN) ๐ถ๏ธ10$-50$ target ๐ฏ
The recent annual numbers from Exagen Inc. show promising results, with revenues exceeding forecasts by 4.4% and statutory losses per share coming in 4.4% smaller than expected. Following these results, analysts have adjusted their earnings model, with revenue forecasts for 2024 now at US$54.2 million, reflecting a 3.1% improvement compared to the last 12 months. Despite the steady losses expected, the consensus price target remains unchanged at US$5.50 per share, indicating that the business is performing in line with estimates. However, there are varying analyst views, with price targets ranging from US$5.00 to US$7.00 per share. It's worth noting that while Exagen's revenue growth is projected to slow down, the wider industry is expected to grow faster. This suggests that while Exagen's performance may be steady, it may lag behind industry peers in terms of growth.